Salarius Pharmaceuticals Soars 311.61% on Reverse Split

On July 29, 2025, Salarius Pharmaceuticals, Inc. (SLRX) experienced a remarkable surge, rising by 311.61% in pre-market trading, marking a significant milestone for the company.

Salarius Pharmaceuticals, Inc. recently filed an 8-K report, detailing the vesting schedule for Restricted Stock Units (RSUs). The schedule includes a 25% vesting on the anniversary of the start date, January 24, 2022, followed by quarterly vesting of 6.25%. This routine vesting and mandatory tax withholding are part of the company's standard operational procedures.

Additionally, Salarius Pharmaceuticals, Inc. has undergone a corporate action, performing a 1-for-8 reverse stock split. This action is aimed at increasing the stock price and potentially attracting more investors by making the stock more accessible and liquid.